PubMed:7559881
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 20-65 | RNA | denotes | vitamin D receptor messenger ribonucleic acid |
| T2 | 354-383 | DNA | denotes | vitamin D receptor (VDR) gene |
| T3 | 528-568 | DNA | denotes | restriction fragment length polymorphism |
| T4 | 618-626 | DNA | denotes | VDR gene |
| T5 | 819-822 | protein | denotes | VDR |
| T6 | 920-937 | RNA | denotes | VDR messenger RNA |
| T7 | 977-989 | DNA | denotes | DNA sequence |
| T8 | 1317-1320 | protein | denotes | VDR |
| T9 | 1352-1364 | DNA | denotes | VDR genotype |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 7559881-0#20#38#gene7421 | 20-38 | gene7421 | denotes | vitamin D receptor |
| 7559881-0#93#107#diseaseC0020438 | 93-107 | diseaseC0020438 | denotes | hypercalciuria |
| 20#38#gene742193#107#diseaseC0020438 | 7559881-0#20#38#gene7421 | 7559881-0#93#107#diseaseC0020438 | associated_with | vitamin D receptor,hypercalciuria |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 82-107 | NP | denotes | absorptive hypercalciuria |
| C2 | 109-162 | NP | denotes | Absorptive hypercalciuria (a stone-forming condition) |
| C3 | 183-255 | NP | denotes | gut hyperabsorption of calcium, hypercalciuria, and reduced bone density |
| C4 | 269-283 | NP | denotes | these features |
| C5 | 350-383 | NP | denotes | the vitamin D receptor (VDR) gene |
| C6 | 423-432 | NP | denotes | this gene |
| C7 | 453-490 | NP | denotes | intestinal hyperabsorption of calcium |
| C9 | 614-626 | NP | denotes | the VDR gene |
| C8 | 593-626 | NP | denotes | different alleles of the VDR gene |
| C10 | 630-697 | NP | denotes | a group of 33 well characterized absorptive hypercalciuric patients |
| C11 | 702-761 | NP | denotes | a group of 36 normal race- and age-matched control subjects |
| C12 | 815-830 | NP | denotes | the VDR alleles |
| C13 | 834-856 | NP | denotes | the patient population |
| C14 | 876-897 | NP | denotes | the normal population |
| C15 | 1148-1190 | NP | denotes | the enhanced intestinal calcium absorption |
| C16 | 1210-1235 | NP | denotes | absorptive hypercalciuria |
| C17 | 1262-1275 | NP | denotes | this disorder |
| R1 | C2 | C1 | coref-ident | Absorptive hypercalciuria (a stone-forming condition),absorptive hypercalciuria |
| R2 | C4 | C3 | coref-ident | these features,"gut hyperabsorption of calcium, hypercalciuria, and reduced bone density" |
| R3 | C6 | C5 | coref-ident | this gene,the vitamin D receptor (VDR) gene |
| R4 | C9 | C6 | coref-ident | the VDR gene,this gene |
| R5 | C12 | C8 | coref-ident | the VDR alleles,different alleles of the VDR gene |
| R6 | C13 | C10 | coref-ident | the patient population,a group of 33 well characterized absorptive hypercalciuric patients |
| R7 | C14 | C11 | coref-ident | the normal population,a group of 36 normal race- and age-matched control subjects |
| R8 | C15 | C7 | coref-ident | the enhanced intestinal calcium absorption,intestinal hyperabsorption of calcium |
| R9 | C16 | C2 | coref-ident | absorptive hypercalciuria,Absorptive hypercalciuria (a stone-forming condition) |
| R10 | C17 | C16 | coref-ident | this disorder,absorptive hypercalciuria |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-108 | Sentence | denotes | Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. |
| S2 | 109-256 | Sentence | denotes | Absorptive hypercalciuria (a stone-forming condition) is characterized by gut hyperabsorption of calcium, hypercalciuria, and reduced bone density. |
| S3 | 257-491 | Sentence | denotes | Inasmuch as these features implicate enhanced calcitriol action in gut and bone, we analyzed the vitamin D receptor (VDR) gene to ascertain whether an abnormality of this gene marks patients with intestinal hyperabsorption of calcium. |
| S4 | 492-762 | Sentence | denotes | We have compared the frequency of a restriction fragment length polymorphism (Bsm I) associated with different alleles of the VDR gene in a group of 33 well characterized absorptive hypercalciuric patients and a group of 36 normal race- and age-matched control subjects. |
| S5 | 763-898 | Sentence | denotes | There was no difference between the distribution of the VDR alleles in the patient population when compared with the normal population. |
| S6 | 899-1100 | Sentence | denotes | The coding region of VDR messenger RNA was also normal, as determined by both DNA sequence analysis and chemical mismatch cleavage analysis of copy DNA from 11 index absorptive hypercalciuric patients. |
| S7 | 1101-1365 | Sentence | denotes | On the basis of these results, we propose that the enhanced intestinal calcium absorption invariably seen in absorptive hypercalciuria and attendant symptoms of this disorder are not attributable to mutations of the VDR and are not linked to a common VDR genotype. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 20-38 | protein_family_or_group | denotes | vitamin D receptor |
| T2 | 93-107 | other_name | denotes | hypercalciuria |
| T3 | 109-119 | other_name | denotes | Absorptive |
| T4 | 120-134 | other_name | denotes | hypercalciuria |
| T5 | 138-161 | other_name | denotes | stone-forming condition |
| T6 | 183-186 | body_part | denotes | gut |
| T7 | 206-213 | atom | denotes | calcium |
| T8 | 215-229 | other_name | denotes | hypercalciuria |
| T9 | 243-255 | other_name | denotes | bone density |
| T10 | 303-313 | lipid | denotes | calcitriol |
| T11 | 324-327 | body_part | denotes | gut |
| T12 | 332-336 | body_part | denotes | bone |
| T13 | 354-372 | protein_family_or_group | denotes | vitamin D receptor |
| T14 | 374-377 | protein_family_or_group | denotes | VDR |
| T15 | 439-447 | multi_cell | denotes | patients |
| T16 | 453-479 | other_name | denotes | intestinal hyperabsorption |
| T17 | 483-490 | atom | denotes | calcium |
| T18 | 528-568 | DNA_domain_or_region | denotes | restriction fragment length polymorphism |
| T19 | 570-575 | DNA_substructure | denotes | Bsm I |
| T20 | 618-621 | protein_family_or_group | denotes | VDR |
| T21 | 663-688 | multi_cell | denotes | absorptive hypercalciuric |
| T22 | 689-697 | multi_cell | denotes | patients |
| T23 | 745-761 | multi_cell | denotes | control subjects |
| T24 | 819-822 | protein_family_or_group | denotes | VDR |
| T25 | 838-856 | other_name | denotes | patient population |
| T26 | 880-897 | other_name | denotes | normal population |
| T27 | 920-923 | protein_family_or_group | denotes | VDR |
| T28 | 977-989 | DNA_domain_or_region | denotes | DNA sequence |
| T29 | 1059-1090 | multi_cell | denotes | index absorptive hypercalciuric |
| T30 | 1091-1099 | multi_cell | denotes | patients |
| T31 | 1161-1171 | other_name | denotes | intestinal |
| T32 | 1172-1179 | atom | denotes | calcium |
| T33 | 1210-1220 | other_name | denotes | absorptive |
| T34 | 1221-1235 | other_name | denotes | hypercalciuria |
| T35 | 1240-1258 | other_name | denotes | attendant symptoms |
| T36 | 1317-1320 | protein_family_or_group | denotes | VDR |
| T37 | 1352-1355 | protein_family_or_group | denotes | VDR |